Tenax Therapeutics (TENX) Change in Inventory (2010 - 2014)
Tenax Therapeutics recorded quarterly Change in Inventory of -$97437.0 in Q2 2014, down 3163.13% quarter-over-quarter from -$2986.0 in Q1 2014, and down 1215.61% year-over-year from $8734.0 in Q2 2013.
Tenax Therapeutics' Change in Inventory history runs 5 years deep, the most recent figure standing at -$97437.0 for Q2 2014.
- In Q2 2014, Change in Inventory fell 1215.61% year-over-year to -$97437.0; the TTM figure through Dec 2015 stood at -$100423.0 (changed N/A YoY), while the FY2014 annual figure was -$99204.0, down 390.43% from the prior year.
- Change in Inventory came in at -$97437.0 for Q2 2014 at Tenax Therapeutics, down from -$2986.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $152048.0 in Q2 2011 to a low of -$97437.0 in Q2 2014.
- A 5-year average of $6957.1 and a median of $1185.0 in 2013 frame the typical range for Change in Inventory.
- Across the five-year window, Change in Inventory soared 111.37% in 2012 and sank 1215.61% in 2014, its largest moves.
- Tenax Therapeutics' Change in Inventory stood at -$45572.0 in 2010, then gained by 7.78% to -$42027.0 in 2011, then jumped by 111.37% to $4780.0 in 2012, then slumped by 80.1% to $951.0 in 2013, then sank by 10345.74% to -$97437.0 in 2014.
- According to Business Quant data, Change in Inventory over the past three periods registered -$97437.0, -$2986.0, and $951.0 for Q2 2014, Q1 2014, and Q4 2013 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 665.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 97.70 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -26.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.32 Mn |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2014 | -97,437.00 |
| Apr 30, 2014 | -97,437.00 |
| Jan 31, 2014 | -2,986.00 |
| Jan 31, 2014 | -2,986.00 |
| Oct 31, 2013 | 951.00 |
| Oct 31, 2013 | 951.00 |
| Jul 31, 2013 | 268.00 |
| Jul 31, 2013 | 268.00 |
| Apr 30, 2013 | 8,734.00 |
| Apr 30, 2013 | 8,734.00 |
| Jan 31, 2013 | 1,419.00 |
| Jan 31, 2013 | 1,419.00 |
| Oct 31, 2012 | 4,780.00 |
| Oct 31, 2012 | 4,780.00 |
| Jul 31, 2012 | -35,161.00 |
| Jul 31, 2012 | -35,161.00 |
| Apr 30, 2012 | 33,336.00 |
| Apr 30, 2012 | 33,336.00 |
| Jan 31, 2012 | -20,987.00 |
| Jan 31, 2012 | -20,987.00 |
| Oct 31, 2011 | -42,027.00 |
| Oct 31, 2011 | -42,027.00 |
| Jul 31, 2011 | 22,398.00 |
| Jul 31, 2011 | 22,398.00 |
| Apr 30, 2011 | 152,048.00 |
| Apr 30, 2011 | 152,048.00 |
| Jan 31, 2011 | 33,614.00 |
| Jan 31, 2011 | 33,614.00 |
| Oct 31, 2010 | -45,572.00 |
| Oct 31, 2010 | -45,572.00 |
| Jul 31, 2010 | 97,936.00 |
| Jul 31, 2010 | 97,936.00 |